Advocate Lutheran General Hospital
Park Ridge, Illinois, 60068, United States
NCT Number: NCT02660996
The objective of this observational study is to assess the effectiveness of the Advocate Lutheran General Survivorship Center's Programs by measuring the following outcomes of interest on participating patients:
1. Quality of life 2. Distress level 3. Satisfaction with the Survivorship Program
General Hypothesis: Patients who participate in at least four classes in a two month period will have higher scores on the post-class satisfaction, quality of life, and distress surveys compared to their pre-class surveys.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Park Ridge, Illinois, 60068, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Time frame: 6-8 months
Questionnaire that includes 36 questions and asks how patients feel their illness has impacted them and their lifestyle with scoring as noted.
Time frame: 6-8 months
The tool asks patients 39 questions about practical, family, emotional, religious, and physical problems in a "yes" or "no" format. A "yes" will scored as 0 and a "no" will be scored as 1. Therefore, the lower the stress level, the higher the score. The scores will be added for a total score.
Time frame: 6-8 months
Questionnaire that includes 8 questions that indicate how satisfied the patients are with the classes offered at the Survivorship Center.
Wake Forest University Health Sciences
Other
Assessing the Effectiveness of the Advocate Lutheran General Survivorship Center Programs on Patients' Quality of Life, Distress Level, and Satisfaction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06654869
Cancer, Neoplasms
Erzurum, Yakutiye, Turkey (Türkiye)
View Trial DetailsNCT04444544
Cancer, Frailty
Geneva, Switzerland
View Trial DetailsNCT02362750
Cancer, Neoplasms
Washington D.C., District of Columbia, United States
View Trial DetailsNCT03060096
Anxiety, Anxiety Disorders
Fort Smith, Arkansas, United States
View Trial Details